The tumor-promoting effects of IL-23 appear to be independent of IL-17 (ref. 16), and ablation of IL-23 is associated with an enhanced infiltration of CD8+ T cells, natural killer (NK) cells and Treg cells14,15,17. The gene discussed is IL23A; the disease is neoplasm.